Skip to main content

Advertisement

Table 5 Descriptive analysis of participant self-reported outcomes for participants who had data at baseline and 3–5 days, by study arm

From: Managing uncertain recovery for patients nearing the end of life in hospital: a mixed-methods feasibility cluster randomised controlled trial of the AMBER care bundle

Primary outcome measures Baseline, mean (SD) 3–5 days, mean (SD) 10–15 days, mean (SD)
IPOS subscale 5 Control, N = 12 13.3 (4.8) 13.3 (3.9) 10.3 (1.2) 1
Intervention, N = 12 13.3 (5.1) 14.6 (4.1) 13.9 (5.3) 2
howRwe 6 Control, N = 8 13.1 (2.5) 13.9 (2.5) 14 (2.0) 3
Intervention, N = 2 11.5 (2.1) 12.0 (0) 11 (N/A)4
  1. 1N = 3
  2. 2N = 7
  3. 3N = 3
  4. 4N = 1
  5. 5 A higher score is worse for patients. For the subscale, seven items are scored 0–4. Possible scores range from 0 to 28
  6. 6 A higher score is better. Four items are scored 1–4. Possible scores range from 4 to 16
  7. SD standard deviation